Adage Capital Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,950,000
Closed -$7.27M 915
2020
Q3
$7.27M Hold
1,950,000
0.02% 574
2020
Q2
$8.5M Hold
1,950,000
0.02% 547
2020
Q1
$7.39M Hold
1,950,000
0.02% 521
2019
Q4
$12.3M Hold
1,950,000
0.03% 495
2019
Q3
$8.21M Buy
1,950,000
+500,000
+34% +$2.14M 0.02% 554
2019
Q2
$6.74M Buy
+1,450,000
New +$6.75M 0.02% 579
2017
Q2
Sell
-750,000
Closed -$1.43M 780
2017
Q1
$1.43M Buy
750,000
+250,000
+50% +$482K ﹤0.01% 670
2016
Q4
$875K Buy
+500,000
New +$1.02M ﹤0.01% 665
2015
Q3
Sell
-800,000
Closed -$6.37M 811
2015
Q2
$6.37M Hold
800,000
0.02% 611
2015
Q1
$8.4M Hold
800,000
0.02% 583
2014
Q4
$9.62M Sell
800,000
-600,000
-43% -$9.12M 0.02% 544
2014
Q3
$23.9M Sell
1,400,000
-850,000
-38% -$12.3M 0.06% 355
2014
Q2
$27.2M Sell
2,250,000
-500,000
-18% -$4.74M 0.07% 324
2014
Q1
$23.2M Buy
2,750,000
+450,000
+20% +$3.63M 0.06% 354
2013
Q4
$13.5M Hold
2,300,000
0.04% 475
2013
Q3
$12.5M Hold
2,300,000
0.04% 463
2013
Q2
$9.34M Buy
+2,300,000
New +$10.8M 0.03% 514

Other funds holding BDSI

Adage Capital Partners's BDSI Position: Q4 2020 in Review

Adage Capital Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2020, closing a stake of 1,950,000 shares — an estimated $7.27M sold.

Adage Capital Partners first reported a position in BDSI in Q2 2013 and held it in 17 quarters. The position peaked at $27.2M in Q2 2014. 145 funds tracked by Wall St. Rank hold BDSI as of Q4 2020.

  • Adage Capital Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2020 after selling out during the quarter.
  • Adage Capital Partners sold 1,950,000 BioDelivery Sciences International, Inc. shares in Q4 2020, an estimated $7.27M.
  • Adage Capital Partners first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 17 quarters.
  • Adage Capital Partners's BioDelivery Sciences International, Inc. position peaked at $27.2M in Q2 2014.
  • 145 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2020.

Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.